Corrected Coronary Opacification Decrease from Coronary Computed

Total Page:16

File Type:pdf, Size:1020Kb

Corrected Coronary Opacification Decrease from Coronary Computed ORIGINAL ARTICLE Corrected coronary opacification decrease from coronary computed tomography angiography: Validation with quantitative 13N-ammonia positron emission tomography Dominik C. Benz, MD,a Christoph Gra¨ni, MD,a Paola Ferro, MD,a Luis Neumeier,a Michael Messerli, MD,a Mathias Possner, MD,a Olivier F. Clerc, MD,a Catherine Gebhard, MD,a Oliver Gaemperli, MD,a Aju P. Pazhenkottil, MD,a Philipp A. Kaufmann, MD,a and Ronny R. Buechel, MDa a Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland Received Mar 25, 2017; accepted Jun 7, 2017 doi:10.1007/s12350-017-0980-2 Background. To assess the functional relevance of a coronary artery stenosis, corrected coronary opacification (CCO) decrease derived from coronary computed tomography angiography (CCTA) has been proposed. The present study aims at validating CCO decrease with quantitative 13N-ammonia positron emission tomography (PET) myocardial perfusion imaging (MPI). Methods and Results. This retrospective study consists of 39 patients who underwent hybrid CCTA/PET-MPI. From CCTA, attenuation in the coronary lumen was measured before and after a stenosis and corrected to the aorta to calculate CCO and its decrease. Relative flow reserve (RFR) was calculated by dividing the stress myocardial blood flow (MBF) of a vessel territory subtended by a stenotic coronary by the stress MBF of the reference territories without stenoses. RFR was abnormal in 11 vessel territories (27%). CCO decrease yielded a sensitivity, specificity, negative predictive value, positive predictive value, and accuracy for prediction of an abnormal RFR of 73%, 70%, 88%, 47%, and 70%, respectively. Conclusions. CCTA-derived CCO decrease has moderate diagnostic accuracy to predict an abnormal RFR in PET-MPI. However, its high negative predictive value to rule out functional relevance of a given lesion may confer clinical implications in the diagnostic work-up of patients with a coronary stenosis. (J Nucl Cardiol 2019;26:561–8.) Key Words: Corrected coronary opacification Æ quantitative PET myocardial perfusion imaging Æ relative flow reserve See related editorial, pp. 569–573 Electronic supplementary material The online version of this Dominik C. Benz and Christoph Gra¨ni share first authorship; Philipp article (doi:10.1007/s12350-017-0980-2) contains supplementary A. Kaufmann and Ronny R. Buechel share last authorship material, which is available to authorized users. Reprint requests: Ronny R. Buechel, MD, Department of Nuclear The authors of this article have provided a PowerPoint file, available Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse for download at SpringerLink, which summarizes the contents of the 100, 8091 Zurich, Switzerland; [email protected] paper and is free for re-use at meetings and presentations. Search for 1071-3581/$34.00 the article DOI on SpringerLink.com. Copyright Ó 2017 American Society of Nuclear Cardiology. 561 562 Benz et al. Journal of Nuclear CardiologyÒ Validation of CCO decrease with quantitative PET March/April 2019 Abbreviations considered the gold standard for myocardial perfusion CCO Corrected coronary opacification assessment.19–21 Moreover, the calculation of relative CCTA Coronary computed tomography flow reserve (RFR) from PET-MPI has not only served angiography as the standard of reference for the validation of invasive SPECT Single photon emission computed FFR,22 but has also been shown in some patient tomography populations to yield significantly higher diagnostic PET Positron emission tomography accuracy than stress myocardial blood flow (MBF) or RFR Relative flow reserve coronary flow reserve (CFR).23 The aim of the present MBF Myocardial blood flow study was to validate CCO decrease with stress MBF in CFR Coronary flow reserve PET-MPI and to assess the accuracy of CCO decrease to TAC Time-activity curves predict an abnormal RFR as derived from the gold ICA Invasive coronary angiography standard PET-MPI. PCI Percutaneous coronary intervention METHODS Study Population INTRODUCTION We retrospectively identified 67 patients who underwent hybrid CCTA/PET-MPI at our institution due to known or Low-dose coronary computed tomography angiog- suspected CAD. Exclusion criteria were history of coronary raphy (CCTA) is a valuable non-invasive tool to assess artery bypass surgery and patients who suffered any events coronary artery disease (CAD) with high negative between the CCTA and the PET scan. The study protocol predictive value1 and to guide subsequent treatment was approved by the institutional review board (cantonal strategies.2,3 A limitation of CCTA is its moderate ethics committee, BASEC-Nr. 2016-00177) and informed performance in assessing the functional relevance of a consent was waived for all patients scanned before 2014. For coronary stenosis as is inherently true for any anatomic all patients scanned afterwards, written informed consent test.4 However, proof of functional relevance of a was obtained. No funding was obtained for performing this study. stenosis prior to any revascularization procedure is mandatory to improve outcome.5–7 Consequently, com- bining anatomic information on the coronary arteries CCTA Acquisition and Assessment of CCO derived from CCTA with functional information from Decrease single photon emission computed tomography (SPECT) or positron emission tomography (PET) myocardial Patients underwent contrast-enhanced CCTA on either a perfusion imaging (MPI) either side-by-side or fused as 64-slice scanner (n = 39; LightSpeed VCT or Discovery HD hybrid imaging was established and has been shown to 750, both GE Healthcare, Waukesha, WI, USA) or a 256-slice offer added clinical and prognostic value.8–10 Concur- scanner (n = 28; Revolution CT, GE Healthcare) using helical rently, there is growing interest in parameters derived (n = 4) or axial scanning with prospective ECG-triggering (n = 63) as previously described.24,25 Bolus tracking was directly from CCTA to assess the functional relevance performed and image acquisition was started 4 seconds after of a coronary lesion. Fractional flow reserve from CCTA the signal density reached a predefined (i.e. 120 Hounsfield (FFRCT) has been introduced recently and several units) or a visually detectable threshold in the ascending aorta. prospective trials have lent support to suggest a clinical In order to achieve a target heart rate \65 bpm, intravenous 11,12 role. Calculation of FFRCT, however, currently metoprolol (5-30 mg) was administered prior to scanning if remains a complex and cumbersome process with necessary. Furthermore, all patients received 2.5 mg sublingual limited availability, but easily and quickly derivable isosorbide dinitrate 2 minutes prior to the scan. parameters such as the transluminal attenuation gradient CCO decrease was measured for each coronary stenosis (TAG)13,14 and the decrease in corrected coronary (i.e. luminal diameter narrowing C50%) as previously 15 opacification (CCO)15–17 have emerged as promising described. In brief, a region of interest (ROI) with a diameter alternatives. While TAG may be more related to vessel of 1 mm was placed in the center of the coronary lumen and a ROI with a diameter of 10 mm was placed in the descending diameter than to stenosis severity,18 CCO decrease has aorta on the same axial slice. CCO was calculated as the ratio consistently yielded high diagnostic accuracy (79 to of mean attenuation in the coronary ROI over the aortic ROI. 89%) to predict functional relevance of a coronary CCO was measured twice as close as possible to the stenosis 15–17 stenosis. It has, nevertheless, not yet been investi- and due care was taken to avoid calcifications and streak gated in comparison to quantitative PET-MPI which is artifacts in the measurements and the lower values were used Journal of Nuclear CardiologyÒ Benz et al. 563 Volume 26, Number 2;561–8 Validation of CCO decrease with quantitative PET to calculate CCO decrease as the difference of proximal minus RESULTS distal value. Study Population PET Acquisition and RFR Calculation The baseline characteristics of the study population Patients underwent 13N-ammonia PET at rest and during (n = 67) are summarized in Table 1. Twenty-seven adenosine stress at a standard rate (0.14 mg/min/kg) over patients (40%) were referred for exclusion of CAD and 7 minutes with 700-900 MBq of 13N-ammonia administered 40 (60%) for evaluation of known CAD. Twenty-one intravenously into a peripheral vein after 3 minutes into stress. patients (53%) had a stent and 16 (40%) a history of Images were acquired either on a Discovery (LS/RX) PET/CT prior myocardial infarction. Figure 1 depicts screening, scanner or on an Advance PET scanner (both GE Healthcare), inclusion, and eligibility for analysis of the study 19 as previously reported in detail. population in a flow chart. Quantitative MBF and CFR were calculated using the com- mercially available PMOD software (version 3.7; PMOD Technologies Ltd., Zurich, Switzerland) developed and validated CCTA Findings at our institution.26 In brief, a volume of interest (VOI) encompass- ing the left ventricular myocardium was drawn and two more VOIs CCTA ruled out CAD in 26 patients (39%). In 41 were put into the blood pool of the left and right ventricle. patients (61%), 99 stenoses were documented in a total Myocardial and blood-pool time-activity curves (TAC) were of 73 vessels resulting in 18 patients with one-vessel, 14 obtained from dynamic frames corrected for radioisotope decay. patients with two-vessel, and 9 patients
Recommended publications
  • Cardiac CT - Quantitative Evaluation of Coronary Calcification
    Clinical Appropriateness Guidelines: Advanced Imaging Appropriate Use Criteria: Imaging of the Heart Effective Date: January 1, 2018 Proprietary Date of Origin: 03/30/2005 Last revised: 11/14/2017 Last reviewed: 11/14/2017 8600 W Bryn Mawr Avenue South Tower - Suite 800 Chicago, IL 60631 P. 773.864.4600 Copyright © 2018. AIM Specialty Health. All Rights Reserved www.aimspecialtyhealth.com Table of Contents Description and Application of the Guidelines ........................................................................3 Administrative Guidelines ........................................................................................................4 Ordering of Multiple Studies ...................................................................................................................................4 Pre-test Requirements ...........................................................................................................................................5 Cardiac Imaging ........................................................................................................................6 Myocardial Perfusion Imaging ................................................................................................................................6 Cardiac Blood Pool Imaging .................................................................................................................................12 Infarct Imaging .....................................................................................................................................................15
    [Show full text]
  • Assessment of the Coronary Artery in High-Pitch, Dual-Source CT
    CARDIAC IMAGING Iran J Radiol. 2017 July; 14(3):e22024. doi: 10.5812/iranjradiol.22024. Published online 2017 July 1. Research Article Assessment of the Coronary Artery in High-Pitch, Dual-Source CT Aortography Without ECG Synchronization Hyeong Gi Choi,1 Mi Jung Park,1,* Ho Cheol Choi,1 Hye Young Choi,1 Hwa Seon Shin,1 Jae Boem Na,1 Jae Min Cho,1 and Dae Seob Choi1 1Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Chilam-Dong, Jinju City, Gyeongnam-Do, Republic of Korea *Corresponding author: Mi Jung Park, MD, Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, 90, Chilam-Dong, Jinju, Gyeongnam-Do, Republic of Korea. Tel: +82-557508814, Fax: +82-557581568, E-mail: [email protected] Received 2016 December 22; Revised 2017 March 17; Accepted 2017 April 01. Abstract Background: The high pitch, dual source computed tomography (CT) provides motion-free aortic imaging. Objectives: To evaluate the image quality of coronary artery using dual-source CT aortography without electrocardiogram (ECG) synchronization. Patients and Methods: One hundred fifty patients (87 men; mean age; 63.7 ± 13.0 years, mean heart rate; 64.7 ± 6.6 beats/min) with suspected or known aortic disease underwent non-ECG gated, high-pitch, dual-source CT aortography. No beta blocker or ni- troglycerin was administered for the patients. The image quality of each coronary artery segment and its ostium was graded on a three-point scale (excellent, moderate, and non-diagnostic image quality). Results: Most patients (88.7%) showed diagnostic image quality in the ostia of the left main and right coronary artery.
    [Show full text]
  • Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications
    RESEARCH ARTICLE Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications Leila Mostafavi1*, Wanda Marfori2, Cesar Arellano1, Alessia Tognolini1, William Speier3, Ali Adibi1, Stefan G. Ruehm1 1 Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America, 2 Department of Radiological Sciences, University of California Irvine, Irvine, CA, United States of America, 3 Medical Imaging Informatics, Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, United States of America * [email protected] Abstract To assess the correlation between breast arterial calcifications (BAC) on digital mammogra- OPEN ACCESS phy and the extent of coronary artery disease (CAD) diagnosed with dual source coronary Citation: Mostafavi L, Marfori W, Arellano C, computed tomography angiography (CTA) in a population of women both symptomatic and Tognolini A, Speier W, Adibi A, et al. (2015) asymptomatic for coronary artery disease. 100 consecutive women (aged 34 – 86 years) Prevalence of Coronary Artery Disease Evaluated by who underwent both coronary CTA and digital mammography were included in the study. Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Health records were reviewed to determine the presence of cardiovascular risk factors such Calcifications. PLoS ONE 10(4): e0122289. as hypertension, hyperlipidemia, diabetes mellitus, and smoking. Digital mammograms doi:10.1371/journal.pone.0122289 were reviewed for the presence and degree of BAC, graded in terms of severity and extent. Academic Editor: Barry I Hudson, University of Coronary CTAs were reviewed for CAD, graded based on the extent of calcified and non- Miami, UNITED STATES calcified plaque, and the degree of major vessel stenosis.
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • 2012-Nia-Clinical-Guidelines-Avmed
    2012 NIA Standard Clincal Guidelines AvMed Guidelines for Clinical Review Determination Preamble NIA is committed to the philosophy of supporting safe and effective treatment for patients. The medical necessity criteria that follow are guidelines for the provision of diagnostic imaging. These criteria are designed to guide both providers and reviewers to the most appropriate diagnostic tests based on a patient‘s unique circumstances. In all cases, clinical judgment consistent with the standards of good medical practice will be used when applying the guidelines. Guideline determinations are made based on the information provided at the time of the request. It is expected that medical necessity decisions may change as new information is provided or based on unique aspects of the patient‘s condition. The treating clinician has final authority and responsibility for treatment decisions regarding the care of the patient. Guideline Development Process These medical necessity criteria were developed by NIA for the purpose of making clinical review determinations for requests for diagnostic tests. The developers of the criteria sets included representatives from the disciplines of radiology, internal medicine, nursing, and cardiology. They were developed following a literature search pertaining to established clinical guidelines and accepted diagnostic imaging practices. All inquiries should be directed to: National Imaging Associates, Inc. 6950 Columbia Gateway Drive Columbia, MD 21046 Attn: NIA Associate Chief Medical Officer 2011 National
    [Show full text]
  • Cardiac PET and PET/CT Imaging
    Cardiac PET and PET/CT Imaging M. F. Di Carli and M. J. Lipton, eds. New York, NY: Springer, 2007, 466 pages, $149 Cardiac PET and PET/CT Imaging is a comprehensive, therapy. Chapters 17, 18, and 21 are a must-read for clini- informative, up-to-date, state-of-the-art textbook on newer cal PET, whereas chapters 23 through 26 are informative cardiac imaging technologies and also provides valuable and useful regarding ongoing research and will help one insight into the future of cardiac imaging. The book has 6 keep up with future developments in this evolving field. parts; the first 5 parts or sections are subdivided into several Part 6 comprises multiple case presentations with good chapters that cover a wide spectrum of presently available illustrations and good explanations of image findings, and newer cardiac imaging modalities and future research goals. many are supported with additional relevant correlations or The first 3 parts progress in a systematic and orderly manner, follow-up findings. There are 18 diverse illustrative cases, starting with the basics of PET instrumentation, the princi- including normal study findings, misregistration and atten- ples of PET, PET tracers and radiopharmaceuticals, CT uation correction artifacts, incidental findings, abnormal cardiac anatomy, iodinated contrast agents, radiation safety, high-risk PET/CT scans, myocardial viability, integrated patient preparation, stress protocols, PET and PET/CT pro- myocardial perfusion with assessment of coronary artery tocols, myocardial PET interpretation, and PET quantifica- calcium score, left ventricular function assessment, and CT tion for assessing preclinical coronary artery disease. The coronary angiography. The writing is clear and understand- relative merits of coronary CT angiography and MRI along able; even difficult topics such as physics, radiochemistry, with integrated assessment of myocardial perfusion using and biochemistry are well presented and are understandable coronary angiography and PET/CT for diagnosing and man- with concentrated reading.
    [Show full text]
  • American College of Radiology – Practice Parameter for Cardiac CT
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2021 (Resolution 45)* ACR–NASCI–SPR PRACTICE PARAMETER FOR THE PERFORMANCE AND INTERPRETATION OF CARDIAC COMPUTED TOMOGRAPHY (CT) PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • Iodinated Contrast Media Guideline
    IODINATED CONTRAST MEDIA GUIDELINE FACULTY OF CLINICAL RADIOLOGY THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS® Name of document and version: Iodinated Contrast Media Guideline, V2.3 Approved by: Faculty of Clinical Radiology Date of approval: March 2018 Suggested Citation: The Royal Australian and New Zealand College of Radiologists. Iodinated Contrast Media Guideline. Sydney: RANZCR; 2018. ABN 37 000 029 863 Copyright for this publication rests with The Royal Australian and New Zealand College of Radiologists ® The Royal Australian and New Zealand College of Radiologists Level 9, 51 Druitt Street Sydney NSW 2000 Australia Email: [email protected] Website: www.ranzcr.edu.au Telephone: +61 2 9268 9777 Disclaimer: The information provided in this document is of a general nature only and is not intended as a substitute for medical or legal advice. It is designed to support, not replace, the relationship that exists between a patient and his/her doctor. Document name Iodinated Contrast Media Guideline Description The Iodinated Contrast Media Guideline is intended to assist The Royal Australian and New Zealand College of Radiologists®, its staff, Fellows, members and other individuals involved in the administration of iodinated contrast media to patients undergoing medical imaging procedures. Created By Standards of Practice and Accreditation Committee Date Created 2011 Maintained By Faculty of Clinical Radiology, Policy and Advocacy Unit Version Number Modifications Made Date Modified 2011 Document published 2.0 Document updated and published April 2016 2.1 Grammatical error corrected in R31 February 2017 2.2 Nitroglycerin dosages corrected in R39 June 2017 2.3 Adrenaline dosage corrected in R56 March 2018 Iodinated Contrast Media Guideline, V2.3 © The Royal Australian and New Zealand College of Radiologists® March 2018 Page 2 of 39 TABLE OF CONTENTS 1.
    [Show full text]
  • RAC Annual Report 2009
    THE ANNUAL REPORT OF THE RADIATION ADVISORY COMMITTEE FOR THE FINANCIAL YEAR ENDING JUNE 2009 RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 ii RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 RADIATION ADVISORY COMMITTEE Melbourne, Australia State of Victoria 2009 ISBN 1035-7912 This document is available on-line at: www.health.vic.gov.au/environment/radiation/committee.htm iii RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 Daniel Andrews MLA Minister for Health Dear Minister Pursuant to Section 110 of the Radiation Act 2005, the Radiation Advisory Committee submits the 2009 annual report of the Committee for presentation to Parliament. Yours faithfully Dr John Heggie Chair RADIATION ADVISORY COMMITTEE iv RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 CONTENTS RADIATION ADVISORY COMMITTEE ...................................................................1 (i) Composition........................................................................................................................ 1 (ii) Responsibilities................................................................................................................... 5 1. INTRODUCTION .........................................................................6 2. IONISING RADIATION...............................................................6 2.1 Research involving irradiation of human volunteers ......................................................... 6 2.2 Radiation incidents............................................................................................................
    [Show full text]
  • Extremely Rare Single Right Coronary Artery, Multidetector Computed
    Arch Cardiol Mex 2012;82(2):195-196 www.elsevier.com.mx IMAGE IN CARDIOLOGY Extremely rare single right coronary artery: multidetector com- puted tomography indings Mauro Echavarría-Pinto, Engels Rodríguez-Rodríguez, Enrico Macías, Eric Kimura- Hayama. Department of Radiology. Instituto Nacional de Cardiología Ignacio Chávez. Mexico City, Mexico. Received on September 9, 2011; accepted on December 9, 2011. KAYWORDS Abstract Coronary anomalies; Mul- Coronary anomalies are rare, with a reported prevalence of 1.3% among patients who undergo tidetector computed to- coronary angiography. The great majority of coronary a rtery anomalies are incidental indings mography; Single right and are not clinically signiicant, but in some cases , may be responsible for angina, syncope, coronary artery; Mexico. arrhythmias or even sudden death. In the following case, we describe coronary CT angiography indings of one of the rarest coronary anomalies. Lip ton R-I type single right coronary artery has only been previously reported in very few occasions and has been seen in only 0.0007% of the population. PALABRAS CLAVE Arteria coronaria derecha única muy infrecuente: hallazgos por tomografía computada Anomalías coronarias; To- multidetector mografía computada mul- ticorte; Arteria coronaria Resumen derecha única; México. Las anomalías congénitas de las arterias coronarias son raras, con una prevalencia estimada de 1.3% en pacientes sometidos a angiografía coronaria. La gran mayoría de estas anomalías no son clínicamente signiicativas, aunque en algunos casos, pueden producir angina, sínco- pe, arritmias e incluso muerte súbita. En el siguiente caso, describimos mediante tomografía computarizada multicorte, una de las anomalías congénitas de las arterias coronarias más raras. La arteria coronaria derecha única tipo R-Ie dLipton, de la que sólo se han reportado muy pocos casos y su prevalencia se estima en 0.0007%.
    [Show full text]
  • High-Pitch Versus Conventional Cardiovascular CT in Patients Being Assessed for Transcatheter Aortic Valve Implantation: a Real-World Appraisal
    Open Access Aortic and vascular disease Open Heart: first published as 10.1136/openhrt-2017-000626 on 8 August 2017. Downloaded from High-pitch versus conventional cardiovascular CT in patients being assessed for transcatheter aortic valve implantation: a real-world appraisal Tevfik F Ismail,1 Emma Cheasty,2 Laurence King,3 Sahar Naaseri,2 Olga Lazoura,2 Natalie Gartland,2 Simon Padley,2,4 Michael B Rubens,2,4 Isabel Castellano,3,4 Edward D Nicol2,4 To cite: Ismail TF, Cheasty E, ABSTRACT KEY QUESTIONS King L, et al. High-pitch versus Objective High-pitch protocols are increasingly used in conventional cardiovascular cardiovascular CT assessment for transcatheter aortic CT in patients being assessed What is already known about this subject? valve implantation (TAVI), but the impact on diagnostic for transcatheter aortic Gated cardiovascular CT can be used to evaluate image quality is not known. valve implantation: a real- the aorta and the coronary arteries in patients being Methods We reviewed 95 consecutive TAVI studies: 44 world appraisal. Open Heart considered for transcatheter aortic valve implantation. (46%) high-pitch and 51 (54%) standard-pitch. Single 2017;4:e000626. doi:10.1136/ It is not known whether newer high-pitch acquisition openhrt-2017-000626 high-pitch scans were performed regardless of heart protocols perform as well as standard-pitch rate. For standard-pitch acquisitions, a separate CT- approaches for coronary and aortic evaluation. aortogram and CT-coronary angiogram were performed TI and EC contributed equally with prospective gating, unless heart rate was ≥70 beats/ and are joint first author What does this study add? min, when retrospective gating was used.
    [Show full text]
  • Procedure Request Form
    EAST HIXSON DOWNTOWN OOLTEWAH DALTON CLEVELAND 1710 GUNBARREL RD. 2070 HAMILL RD. 440 N. HOLTZCLAW AVE. 9368 BRADMORE LANE 1502 N. THORNTON AVE. 2253 CHAMBLISS AVE. N.W. CHATTANOOGA, TN 37421 HIXSON, TN 37343 CHATTANOOGA, TN 37404 OOLTEWAH, TN 37363 DALTON, GA 30720 SUITE 102 CLEVELAND, TN 37311 Phone: 423.553.1234 Fax: 423.553.1235 Patient’s Name _________________________________ Date of Birth _____________ Appointment Date ____________ Time ___________ Patient Email ______________________________________________________________________________________________________ Procedure Requested (If not listed below) ________________________________________________________________________________ Diagnosis __________________________________________________________________________________________________________ Special Instructions ______________________________________________________________________________________________________ Ordering Physician ________________________________ Physician’s Signature________________________________________ Please Print Report: q ROUTINE q URGENT q STAT Call STAT report to ___________________________ at phone # ____________________ at FAX# ____________________ Perform ASAP Call Results Name After hours/direct phone number Critical result findings will be called to referring providers per CI policy. PET/CT SCAN ULTRASOUND q Brain q Body q ABI MRI q Thyroid Contrast at Radiologist discretion unless otherwise indicated q Retroperitoneal (to include aorta, pancreas, kidneys, bladder) q Brain w/3D Reconstruction
    [Show full text]